These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM, Qian X, Schiller PW, Szeto HH. J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [Abstract] [Full Text] [Related]
3. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Traynor JR, Nahorski SR. Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747 [Abstract] [Full Text] [Related]
4. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR. J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532 [Abstract] [Full Text] [Related]
5. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494 [Abstract] [Full Text] [Related]
6. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles. Zhang YQ, Limbird LE. Biochem Soc Trans; 2004 Nov; 32(Pt 5):856-60. PubMed ID: 15494033 [Abstract] [Full Text] [Related]
10. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms. Snook LA, Milligan G, Kieffer BL, Massotte D. J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056 [Abstract] [Full Text] [Related]
15. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application]. Narita M. Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825 [Abstract] [Full Text] [Related]
16. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists. Sánchez-Blázquez P, García-España A, Garzón J. J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133 [Abstract] [Full Text] [Related]
17. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits. Mostany R, Díaz A, Valdizán EM, Rodríguez-Muñoz M, Garzón J, Hurlé MA. Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820 [Abstract] [Full Text] [Related]
18. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. Selley DE, Liu Q, Childers SR. J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589 [Abstract] [Full Text] [Related]